+ 1-971-202-1575 , TollFree:+ 1-800-910-6452
  [email protected]
Vertebral Compression Fracture Devices Market by Product (Balloon Kyphoplasty Devices and Vertebroplasty Devices) and Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery) - Global Opportunity Analysis and Industry Forecast, 2014-2022
  • Published : March , 2017
  • |
  • Number of Pages : 141
  • |
  • Published By : Allied Market Research



Report Overview
Vertebral compression fracture (VCF) is a type of spinal disorder caused by the fracture of bones in the spinal cord due to osteoporosis, arthritis, and trauma. The surgical approach for the treatment of VCF includes vertebroplasty and balloon kyphoplasty. These procedures involve injecting cement in the fractured vertebral body to achieve immediate pain relief and stability.
The global VCF devices market generated $748 million in 2015, and is projected to reach $1,109 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. The market is driven by factors such as increase in geriatric population, rise in incidence of osteoporosis & arthritis, and growth in patient awareness about advancements in spinal surgeries, such as artificial disc replacement. However, risk associated with post-surgical complications, i.e., hemorrhage and vertebral posterior element fracture, and stringent regulatory approval procedures are expected to hamper the market growth.
The global VCF devices market is segmented on the basis on product type, surgery, and region. Based on the type of product, the market is segmented into balloon kyphoplasty and vertebroplasty. Based on the type of surgery, the market is bifurcated into open spine surgery and minimally invasive spine surgery. The market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
The key players have adopted product development strategies, including product launches, approvals, and clinical trials over the past few years. For instance, in 2014, Benvenue Medical commercially launched Kiva VCF treatment featuring a proprietary, cylindrical implant obtained from a medical polymer that provides a predictable structural support for the vertebral body, and a reservoir to contain and direct the flow of bone cement. 
KEY BENEFITS FOR STAKEHOLDERS

This report offers an extensive analysis of the current trends and emerging estimations of the global VCF devices market for the period of 2014–2022 to identify the prevailing opportunities
Comprehensive analysis of all geographical regions is provided along with the factors that drive and restrict the market growth.
Quantitative analysis of the market segments is provided for the period of 2014-2022 to showcase the financial scenario.
The regional and country-level analyses of the market are provided in the report.

KEY MARKET SEGMENTS
By Product    

Balloon Kyphoplasty Devices
Vertebroplasty Devices

By Surgery

Open Spine Surgery
Minimally Invasive Spine Surgery

By Region

North America


U.S.

Canada

Mexico


Europe


France

Germany

UK

Spain

Italy

Rest of Europe


Asia-Pacific


Japan

China

Australia

India

South Korea

Rest of Asia-Pacific


LAMEA


Brazil

Saudi Arabia

South Africa

Rest of LAMEA



The key companies operating in the VCF devices market that are profiled in the report are as follows:

Alphatec Holdings, Inc.
Benvenue Medical
Depuy Synthes (Johnson & Johnson)
Globus Medical, Inc.
Medtronic plc
Orthovita, Inc.
Osseon LLC
Stryker Corporation
VEXIM SA
Zimmer Biomet Holdings, Inc.

The other major players operating in this market include:

Algea Therapies
Spine Wave, Inc.
Spirit Spine
Stöckli Medical AG



Similar Market Studies

PUBLISHED REPORTS


UPCOMING REPORTS


Reports and Intelligence


We Accept

  • Stay Connected

Copyright ©2017 Reportsandintelligence All Rights Reserved